Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 260

Emailed: 0

PDF Downloaded: 692


Rupa, Jagadeeswari, Rajani, and Hanumanthu: Histopathological spectrum of ovarian tumors – A prospective study at a tertiary care centre in Srikakulam


Introduction

The ovaries are paired intrapelvic organs and are the common site for origin of both benign and malignant neoplasms.1 Ovarian tumours (OTs) can occur in all age groups, account for 20% of benign and 6% of malignant cases. These are the 7th most common cancer in women and 8th most common cause of cancer death worldwide.2 Most of these are benign. 3

In addition to primary tumours, ovaries are also the favourite site for metastatic tumors.4 Increasing age, nulliparity, lower fertility and so on are the risk factors of OTs.2 The incidence of different types of OTs is varies but an increased trend of is been observed since 1982.1 As per recent statistics, in Asian countries the OTs occur at a rate of 2 to 6 new cases for 100,000 women per year.4 Ovarian cancer incidence vary among different ethnic groups such as non-hispanic women have higher rates than Hispanic women. 2 Due to the high frequency of BRCA mutations, the incidence of OTs is 8 times more among the Jewish women.2

The risk for development of ovarian cancer in women carrying BRCA1 mutations is 44%. 2 Lynch syndrome occurs secondary to mutations. Women with Lynch syndrome are potentially at increased risk of developing clear cell carcinoma, endometrial carcinoma and colorectal carcinoma at a very younger age.5

The OTs are either asymptomatic or present with vague symptoms like abdominal pain, mass per abdomen etc.3 There is no availability of definite screening tests and also difficult to distinguish on the basis of clinical, radiological and gross characteristics. Therefore, the histopathological study is of utmost important in identifying the type of tumour and considered to be gold standard.6

With this a study was conducted to categorize OTs based on histopathology, to analyse with respect to the age and classify according to WHO guidelines.

Materials and Methods

This was a prospective, cross-sectional study conducted in the department of Pathology, government Medical College, RIMS, Srikakulam. Study was conducted from July 2019 to December 2020, over a period of 18 months. Study protocol was approved by the institutional ethics committee. An informed written consent was taken from the study participants.

Women, aged >18yrs, suspected to be OTs, were included in the study. Women with cysts, endometriosis, those who were non cooperative and didn’t submit the consent were not considered in this research. All the eligible members who satisfy the inclusion criteria were considered in this study.

Detailed clinical history was taken from all the study participants and it was recorded. Specimen in the form of partial or total abdominal hysterectomy were considered. On the receipt of the clinical specimen, the gross examination was done. The features such as size, color of specimen were noted. As a part of the study, the external surface features and contents were noted, also recorded in the study proforma.

The specimens were fixed in 10% formalin. From the clinical specimen, 2 to 4 mm thick slices were taken from multiple as well as relevant areas. The tissues were thoroughly processed and subjected to paraffin wax embedding. Sections were mounted on a glass slide and cleared with xylene. Sections were then stained with haematoxylin and eosin. Each biopsy was labelled explicitly according to the orientation of the biopsy site and sent for histopathological examination. The stained sections were examined under the light microscope for histopathological diagnosis.The tumours were classified according to World Health Organisation (WHO) classification of female genital tumors-2020.

Statistical analysis

The data were analysed using SPSS version 21.0. Descriptive analysis was made from the data and presented in mean, percentages.

Results

Total 62 (100%) tumors were diagnosed in this study. Among these, 90% were benign tumors (BET). Malignant tumors (MLT) constituted to be in the second (8%; 5) position and the borderline tumors (BLT) were in the third category, 1 (1.62%). (Table 1)

Age wise, majority (29%; 18) were in 31 – 40 years group but all these were BET. Next to this, 24% (15) of OTs were detected in 41 – 50 years group; in this 17.8% (11) were BET, 4.8% (3) were MLT and just 1 (1.6%) was BLT. Another 19.4% (12) BETs were detected in 21 – 30 years group. Next to this, 9.67% (6) each OTs were detected in 61 – 70 and <20 years groups, respectively; but there was just 1 MLT was detected in <20 years group and another 01 in 51 – 60 years (Table 2).

Out of the 5 MLTs in this study, 03 (4.8%) were Surface epithelial tumours (SETs) and 2 (3.2%) were Germ cell tumours (GCTs). All (01; 1.62%) the BLTs were SETs and in the BETs, 76% (47) were SETs and 14.5% (9) were GCTs. Total, 51 (82.26%) SETs and 11 (17.74%) GCTs (Table 3).

Table 1

Distribution different OTs among the study members

Type of tumor

Number

%

Benign

56

90.32

Malignant

05

8

Borderline

01

1.62

Total

62

100

Table 2

Age wise distribution of OTs among the study participants; n (%)

Age

Benign

Borderline

Malignant

Total

< 20

05 (8)

-

01(1.6)

06 (9.67)

21 – 30

12 (19.4)

-

-

12 (19.4)

31 – 40

18 (29)

-

-

18 (29)

41 – 50

11 (17.8)

01 (1.6)

03(4.8)

15 (24)

51 – 60

04 (6.45)

-

01(1.6)

05 (8)

61 – 70

06 (9.67)

-

-

06 (9.67)

Total

56 (90.32)

01(1.62)

05(8)

62 (100)

Table 3

Types of OTs according to histology findings; n (%)

Type

Benign

Borderline

Malignant

Total

Surface epithelial tumours

47 (76)

01 (1.62)

03 (4.8)

51 (82.26)

Sex cord stromal tumours

-

-

-

-

Germ cell tumours

09 (14.5)

-

02 (3.2)

11 (17.74)

Total

56 (90.32)

01(1.62)

05 (8.06)

62 (100)

Figure 1

Microphotograph of borderline serous tumour showing hierarchical branching papillae (40X, H&E)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/801708b0-c864-47b3-843b-92705d7d784fimage1.png
Figure 2

Gross photograph ofGranulosa cell tumour with mature cystic teratoma

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/801708b0-c864-47b3-843b-92705d7d784fimage2.png
Figure 3

Microphotograph ofgranulosa cell tumour with mature cystic teratoma showing microfollicular pattern (40X, H&E).

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/801708b0-c864-47b3-843b-92705d7d784fimage3.png

Discussion

The ovary is the complex structure in its embryology, repeated rupture during ovulation and repair may result in malignant gene mutations. The OTs can occur in any age but common in the reproductive age. 6 In our study the maximum number (53.58%) of tumours were observed between 21 – 40 years group. The sexually active group is usually prone for developing the OTs. Similar observations were reported by Verma K and Bhatia A et al. 7 and Ashraf et al. 8

In our study majority of cases (82.26%) were SETs. Similar observations were reported in the literature. 9, 10, 11, 12, 13 Traditionally these tumours were thought to arise from the ovarian surface epithelium, hence referred as SETs. Now it has been clear that these tumours have diverse cell of origin. 5 These tumours resemble the tissues of Mullerian origin, which was also confirmed by immunohistochemical studies. 2 The serous tumours (STs) resemble the tubal epithelium, whereas the endometroid and clear cell tumours are similar to endometrial tissue.

High grade serous carcinoma constitutes majority of type II tumours, according to the recent data which arises from a precursor lesion, serous tubal intra epithelial lesion. 2 In this report, among the SETs, majority (62.63%) were serous tumours. Similar observations were made by Ranjana H et al. 1 In our study, we reported 35 cases of STs, out of which 91.5% (32) were BET, 2.9%(1) were BOT and 5.8% (2) were MLTs. STs accounts to 25% of all the ovarian neoplasms. 5 Majority of the tumours were seen in adults. In the past, it was thought that high grade serous carcinomas arise from low grade serous neoplasms, but now it was recognised that they differ in the cell and site of origin, molecular events during pathogenesis and response to chemotherapy. 5

One case of borderline ST was reported in our study. Serous borderline tumour is a non-invasive, low grade neoplasm, usually seen around 50 years of age. Prognosis is good with these tumours, survival of patients with stage I tumour is similar to that general population.2 We received a cystic mass of size 5×3.5×2.5cm. Surface was smooth. On cut section, cyst was filled with serous fluid and multiple papillary projections were seen. Microscopic examination revealed multiple long hierarchical branching papillae lined by cuboidal epithelium showing mild pleomorphism and stratification. (Figure 1) Two cases of high-grade serous carcinomas were also reported in our study. Both the cases have showed bilateral ovarian involvement and on microscopic examination they showed a solid, glandular and papillary architecture with cells exhibiting marked cytological atypia, high mitotic activity and atypical mitosis. These tumours are associated with higher rates of recurrence and poor prognosis.

In our study, we reported a rare case of Granulosa cell tumour with mature cystic teratoma occurring synchronously in the same ovary in a 55 year participant. Similar findings were reported in perimenopausal women by Trivedi P et al. 14 It usually occurs in infants and children younger than 10 years of age. 2 It is a rare neoplasm composed of both germ cell and sex cord stromal elements. The microscopic findings revealed individual cells with longitudinal nuclear grooves and characteristic Call - Exner bodies. Sections from the cystic area showed mature squamous epithelium, adipose tissue and salivary gland tissue. (Figure 2)

We have also reported a case of mixed GCT. Similar case was reported by Zareena S et al.15 The GCTs account for 20% of all the OTs.2 The histopathological examination showed immature neuroectodermal tissue occupying less than one low power field in one slide, cartilage, adipose tissue, squamous epithelial islands, bronchial epithelium, glial tissue along with reticular and microcystic areas, schiller- duval bodies and hyaline globules at focal areas. (Figure 3)

Conclusion

In our study, the BETs are more common than malignant counterparts. Thorough study of gross and microscopic features not only help in the proper categorization but also provide a route for treatment plan as the therapeutic approach varies with the subtype of OT. The immunohistochemistry analysis may be an aid if any ambiguity in the diagnosis.

Conflict of Interest

There are no conflicts of interest in this article.

Source of Funding

None.

References

1 

H Ranjana S Sadhna P Ekta Histopathological spectrum of ovarian tumours: A two-year retrospective studyIndian J Pathol Oncol2017434503

2 

JD Siedman BM Ronnett S Ie-Ming RJ Kurman Ellenson LH BM Ronnett Epithelial tumours of the ovaryBlaustein’s Pathology of the Female Genital TractSpringer publishingSwitzerland201984166

3 

LH Ellenson EC Pirog Kumar Abbas Aster The Female Genital TractRobbins & Cotran Pathologic Basis of Disease9th Edn. RELX India Private LimitedFaridabad2018102434

4 

K Rajani K Paparatnam Spectrum of histopathology of ovarain tumours: 3 years studyParipex Indian J Res201984645

5 

B Gilks JR Goldblum LW Lamps JK Mc Kenney JL Myers OvaryRosai and ackerman’s surgical Pathology11th Edn.ElsevierPhiladelphia20181367431

6 

A Dutta R Imran P Saikia M Borgohain Projnan Saikia, Mondita Borgohain. Histopathological spectrum of ovarian neoplasms in a tertiary care hospitalInt J Contemp Med Res20185814

7 

K Verma A Bhatia Ovarian neoplasms-a study of 403 tumoursJ Obstet Gynaecol Ind19813110611

8 

A Ashraf AS Shaikh AI Akram F Kamal N Ahmad The relative frequency and histopathological pattern of ovarian massesBiomed20122898102

9 

F Couto NS Nadkarni MJP Rebello Ovarian tumours in Goa: A clinicopathological studyJ Obstet and Gynaec Ind199343340812

10 

A Phukan M Borgogoi S Ghosh Histopathological spectrum of ovarian tumours: an institutional perspectiveInt J Res Med Sci201868263943

11 

V Manoja M Pramood V Jyothi KPA Chandrashekar Clinicopathological study of ovarian tumors: A 2-year StudyInt J Sci Study2017533005

12 

A Bhagyalakshmi A Sreelekha S Sridevi J Chandralekha G Parvathi A Venkatalakshmi Prospective study of histomorphological patterns of ovarian tumours in a tertiary care centreInt J Res Med Sci20142244856

13 

I Munibhavani V Satyanarayana Study of histopathological spectrum of ovarian neoplasm: An experience at tertiary care hospitalInter J Of Clin and Diag Path20192240813

14 

P Trivedi T Patel R Jain B Parikh P Dave Granulosa cell tumour arising in an ovary with mature teratomaInd J Pathol Microbiol20095245596010.4103/0377-4929.56166

15 

S Zareena N Bharat Acs Kumar Vardhini RH & Rekha A. Malignant ovarian germ cell Tumour- A rare combination of yolk sac tumour and immature teratomaInt J Med Clin Imaging2019426972



jats-html.xsl

© 2023 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)